support, which refers to computer-based tools and systems that offer clinicians and patients assistance for thinking about and solving problems." 1 Tools for cognitively guided decision support are particularly important for primary care clinicians who manage patients with complex chronic diseases, such as diabetes. Chronic disease prevalence, complication rates, and costs are alarmingly high, with many people affected by multiple conditions and disabilities. 2 Furthermore, primary care clinicians face severe time constraints when providing care, 3 and their reimbursement is increasingly tied to quality of care and patient outcomes. 4 Information visualization-"the use of computersupported, interactive visual representations of abstract data to amplify cognition" 5 -has supported many tasks in chronic disease care. Visualizations include color-coded spreadsheet displays, 6 line or bar graphs that show concordance between individual patient measures and benchmark values, 7,8 bar graphs that summarize quality measures across many patients, 7 clinical event timelines, 8, 9 and combinations of these approaches. These tools typically display multiple attributes of a single patient or summarize many patients on a single dimension. However, existing tools are limited in their ability to analyze and display highdimensional data for many patients in a single view.
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Here, we examine a new approach for quantitatively summarizing and visually displaying information on many relevant health dimensions across many patients. Specifi cally, we describe a method and prototype software tool that provide two-dimensional (2D) visualization and risk classifi cation across multiple risk factors. This framework lets clinicians interactively visualize patient information at the population, subpopulation, and individual patient levels. We quantitatively evaluate our framework's ability to visually classify a patient population according to risk of heart attack, thus expanding on its previous application in the context of diabetes onset risk. 10 
Materials and Method Overview
We developed our methodology and prototype software tool for visualizing and stratifying highdimensional patient data using a combination of statistical machine learning and informationvisualization techniques. We developed the prototype's visualization interface in Adobe Flex and intend to implement it in JavaScript/HTML5 for improved scalability and customization. All computations are executed by R statistical software libraries, using Rserve 11 to communicate with the visualization application's Java back end. We tested our tools using an anonymous dataset from the American Diabetes Association (ADA). This dataset contained M = 22 demographic and clinical variables related to heart attack risk for N = 588 people with type 2 diabetes. The variables included age, sex, ethnicity, smoking status, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), LDL cholesterol, HDL cholesterol, most recent HbA1c value, physical activity level, whether the person sees a physician regularly, medical history of angina, albuminuria, cardiac bypass, heart attack, congestive heart failure and heart disease, and medications currently taken (such as aspirin, antihyperglycemics, antihypertensives, or antihyperlipidemics). The data also included each person's risk of having a A ccording to the US-based Institute of Medicine (IOM) and the National Research Council (NRC), the vision for 21st century healthcare includes increased attention to "cognitive heart attack at some point in the next 30 years, estimated using the Archimedes model. 12 However, the risk classification approach we describe here is not limited to 30-year risk, nor does it rely on the Archimedes model. It can use any measure of risk for which labeled data is available.
Methodology and System Development
First, we projected and plotted the data in two dimensions using two statistical dimensionality reduction techniques, principal component analysis (PCA) and linear discriminant analysis (LDA) (Figure 1a ). We used PCA, plotted on the x-axis, because data transformed using the first principal component would be maximally scattered in the resulting one-dimensional space. 13 This visually highlights clinical differences between patients in a view that is simpler than comparing patient data across many variables, such as in a large spreadsheet. LDA, on the other hand, is explicitly concerned with classification and thus is useful for stratifying patients by risk. Given labeled training data from two distinct classes (for instance, low risk of heart attack versus high risk of heart attack), LDA computes a linear data transformation that maximizes the ratio of between-class variance to within-class variance. We used LDA, plotted on the y-axis, because highand low-risk patients should be wellseparated visually when clinicians view the data. 14 The first principal component and linear discriminant together define a linear transformation of each high-dimensional data point Z j into the 2D visualization space: (x j , y j ) T = DZ j , where D is a 2 × M matrix with the first row determined by the first principal component and the second row determined by the linear discriminant; Z j is a column vector of length M; and x j and y j are scalars representing the new coordinates in 2D space.
We next applied informationvisualization techniques to visually recapture some of the information lost by dimensionality reduction and support cognitively guided decision making. First, we added "attracting anchors" 15 to the plot to convey each risk variable's coefficient weights D 1,i 
Each anchor's location conveys the relative size of the two components' coefficients for each variable, which we call the direction of attraction. We express the relative size of the component coefficients between risk factor variables, or the magnitude of attraction, using each anchor's area. We define the anchor area S i to be proportional to the length of the vector formed by the weighting coefficients D 1,i and D 2,i , given as follows: 10
where S i is the area of the plotted anchor and C is a tuning constant set such that the smallest anchors are large enough to be visible. We can use the anchors' size and direction to interpret which risk factor variables have relatively large or small coefficients on each component. For example, if variable i has a large positive coefficient on the first principal component and a large positive coefficient on the linear discriminant, it will be represented by a relatively large anchor located in the plot's upper-right quadrant. Patient data points with larger values for variable i will then be plotted further toward the plot's upper-right quadrant. Our rationale for the anchors was to convey in a single view an understanding of which variables are most influential on risk at the population level and which individuals tend to have higher values for individual risk factor variables. Finally, we added interactive information-visualization techniques to the prototype tool to enable zooming, filtering, and viewing individual patient details as recommended for exploratory information-visualization tasks 16 (Figures 1b-d (Figure 1c) . The software resizes the anchors to visually depict each risk factor's relative impact for that particular individual (Figure 1d ). The system also includes a hypothetical intervention feature that lets users see how prospective interventions or changes in risk factor values would impact the patient's location on the population risk graph (Figure 1d ).
Evaluation
Our quantitative evaluation of our framework focused on its utility for stratifying patients into risk groups. Based on the 30-year heart attack risk probabilities contained in the sample data, we labeled half the data low risk and half high risk of future heart attack. We used naïve Bayes, logistic regression, k-nearest neighbor (k-NN), and support vector machine (SVM) approaches to classify the data. To understand how well our method visually separated low-and high-risk patients, we compared the classification accuracies of these other common methods to that of applying LDA to the data plotted in two dimensions using our described approach. We calculated the classification error for each method using 10-fold cross-validation. Figure 2 shows the visual classifier and includes an LDA-based decision boundary, which separates the patients predicted to be high risk and those predicted to be low risk. The 10-fold cross validation error from the visual classifier was .13, which was similar to or less than the error found after applying other commonly used classification methods to the full-dimensional dataset, including naïve Bayes (. Our framework presents a new approach to organizing and delivering "cognitively guided" data to clinicians. The methodology combines simple yet powerful statistical methods with intuitive data visualizations. The visual classifiers provide a contextualized and potentially more interpretable means of communicating risk information on complex patient populations to time-constrained clinicians. When using the interactive software tool described here, users can navigate from a 2D patient population view to views of individual patients to quickly assess their risk and risk factors, and the effects of interventions.
Our evaluation used a quantitative analysis of classification accuracy and our interpretations of clinical insights depicted in the heart attack risk models. Subsequent interviews and demonstrations with a small sample of diabetes educators, physicians, and patients also suggested these tools' potential usefulness for personalized clinical interventions, risk communication, and patient education. These are necessary first steps in evaluation, but formal clinical usability and usefulness testing is warranted. Through user testing, we might further revise our methods to better align with clinician information needs and decisionmaking processes.
We must also evaluate our visualization models' classification accuracy using other data, including data that comes directly from clinical sources. To achieve this, we plan to acquire longitudinal data containing both risk factors and patient outcomes. Moreover, prior to applying visual classifiers to any patient population that differs significantly from those on which we originally validated them, our models would need additional training and calibration, as has been recommended with other risk assessment models. Finally, this visualization method and tool could extend to other risk-assessment scenarios in healthcare delivery, such as evaluating risks to patient safety and clinical guideline compliance. 
